🔴 Eli Lilly is trading 3% down today after FDA delayed decision on weight-loss pill

Eli Lilly is trading at $1041.07 (-3.00%) after the FDA announced a delay in the decision timeline for its weight-loss pill.

• The FDA decision on the drug has been pushed back to April 10, 2026, from the previously anticipated late-March timeline.
• This decline is significant as it occurs despite broader market gains (S&P 500 up 0.51% and NASDAQ up 0.75%), highlighting company-specific pressure.
• The news initially caused shares to dip 0.9% in premarket trading.